Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
ANTARES PHARMA, INC. (ATRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/29/2021 |
3
| Volkart Carmen B (Director) has filed a Form 3 on ANTARES PHARMA, INC. |
| 04/28/2021 |
3
| Richardson Peter C (EVP, R&D Chief Medical Officer) has filed a Form 3 on ANTARES PHARMA, INC. |
| 03/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/14/2018 |
3
| Greenleaf Peter (Director) has filed a Form 3 on ANTARES PHARMA, INC. |
| 08/07/2018 |
3
| Tursi James Patrick (EVP, Chief Medical Officer) has filed a Form 3 on ANTARES PHARMA, INC. |
| 11/02/2016 |
3
| Powell Fred M (Senior Vice President & CFO) has filed a Form 3 on ANTARES PHARMA, INC. |
| 09/12/2016 |
3
| Muckenhirn Keith E (VP/Controller & Interim CFO) has filed a Form 3 on ANTARES PHARMA, INC. |
| 08/06/2013 |
3
| ROCHE ROBERT P JR (Director) has filed a Form 3 on ANTARES PHARMA, INC. |
| 06/08/2011 |
3
| DAVE KAUSHIK J (Executive Vice President) has filed a Form 3 on ANTARES PHARMA, INC. |
| 08/14/2009 |
3
| HOBBS EAMONN P (Director) has filed a Form 3 on ANTARES PHARMA, INC. |
|
|